Adbiotech Co Ltd
179530
Company Profile
Business description
Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.
Contact
39, Geodudanji 1-gil
Dongnae-myeon
Gangwon-do
Chuncheon24398
KORT: +82 332614907
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
59
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,408.00 | 29.40 | -0.31% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,793.46 | 125.43 | 0.49% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,840.20 | 1,233.49 | 1.88% |
| NZX 50 Index | 13,838.17 | 14.04 | 0.10% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,216.90 | 32.70 | -0.35% |
| SSE Composite Index | 3,945.89 | 5.85 | 0.15% |